Biotechnology News

Rep. Erin Houchin toured Ossium Health's Indianapolis facility, home to the world's first bone marrow bank sourced from deceased organ donors.

Applied Biologics announces Last Patient, Last Visit in CAMPX randomized trial of XWRAP.

Seek Labs has launched the Open Impact Sequence Ablation Therapeutics Program, a new Clinton Global Initiative Commitment to Action.

Publication of results from the Phase 2 BRAVIO clinical trial evaluating intravenous followed by oral varespladib for snakebite.

Wood's independent TEA validated that Eclipse's RenovaStrata™ H2 can achieve modeled LCOH as low as $0.56/kg and carbon intensity of 0.076 kgCO₂e/kgH₂.

WALTHAM, Mass., Sept. 22, 2026 (GLOBE NEWSWIRE) -- X-Chem, a global leader in innovative drug discovery services, announced the achievement of a milestone following Relay Therapeutics’ initiation of...

Strong pace of patient enrollment supports continued advancement toward regulatory milestones Most recent assessment of novel telomere targeting agent sequenced with a checkpoint inhibitor showed...

First patient marks Polyrizon’s transition into a clinical-stage company. The U.S clinical study is designed to evaluate the efficacy, safety and tolerability of the NASARIX (PL-14) Allergy Blocker...

Founder and CEO Kevin Slawin, M.D., to deliver industry keynote on advancing mitochondrial-targeted geropeptide medicineEos advancing lead candidate MitoXcel™ geropeptide PTC-2105 toward...

Independent Data Monitoring Committee recommends the ongoing Phase 2 MRD study continue without modification following its review of all safety data to date No cytokine release syndrome, systemic...